Systemic lupus erythematosus with initial presentation of empyematous pleural effusion in an elderly male patient: A diagnostic challenge  by Chang, Wei-Ting et al.
Journal of Microbiology, Immunology and Infection (2013) 46, 139e142Available online at www.sciencedirect.com
journal homepage: www.e- jmii .comCASE REPORT
Systemic lupus erythematosus with initial
presentation of empyematous pleural effusion
in an elderly male patient: A diagnostic challengeWei-Ting Chang a, Tung-Han Hsieh a,b,*, Ming-Fei Liu a,caDepartment of Internal Medicine, National Cheng Kung University College of Medicine and Hospital,
Tainan City, Taiwan, ROC
bDivision of General Medicine and Cardiology, National Cheng Kung University College of Medicine and Hospital,
Tainan City, Taiwan, ROC
cDivision of Rheumatology, National Cheng Kung University College of Medicine and Hospital, Tainan City, Taiwan, ROC
Received 6 September 2011; received in revised form 13 October 2011; accepted 17 November 2011KEYWORDS
Elderly male;
LE cell;
Pleural effusion;
Systemic lupus
erythematous* Corresponding author. Departme
National Cheng Kung University Colle
Number 138, Sheng Li Road, East Distr
ROC.
E-mail address: mevalotin2000@ya
1684-1182/$36 Copyright ª 2011, Taiw
doi:10.1016/j.jmii.2011.12.032Systemic lupus erythematosus (SLE) poses great difficulty in making an early diagnosis in
elderly males, often presenting with atypical manifestations. Acute onset of empyematous
pleural effusion has rarely been seen. Herein, we report a 66-year-old man with SLE presenting
with rapid progression of bilateral pleural effusion. Diagnostic thoracocentesis disclosed
neutrophil-predominant exudates and chest computed tomography revealed multiple locu-
lated pleural effusions. Nevertheless, optimal antibiotic therapy plus surgical decortication
of the pleura did not improve his condition. The diagnosis of SLE was readily established after
LE cells were accidentally found in the pleural effusion. Large amounts of pleural effusion
subsided soon after high dose corticosteroid therapy.
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Systemic lupus erythematosus (SLE) is an autoimmune
inflammatory disease involving multiple organs. It mostly
affects young and middle-aged females and is diagnosed by
American College of Rheumatology (ACR) criteria. However,
a wide spectrum of clinical manifestations is common and
early diagnosis is crucial to potentially fatal complications.
Male geriatric patients with SLE are easily missed orished by Elsevier Taiwan LLC. All rights reserved.
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these groups and atypical clinical presentations. We report
an elderly male SLE patient who initially presented with
empyematous pleural effusion. Interestingly, the rapid
diagnosis of SLE was due to the accidental observation of LE
cells in the pleural effusion.Case report
A 66-year-old male with hypertension who previously had
medical therapy, was admitted for fever and dyspnea
lasting several days. One week previously, he had been
hospitalized for left pneumonia with parapeumonic effu-
sion. After treatment with empirical antibiotics for 3 days,
even though no specific pathogen was isolated, he felt
better and was discharged, against advice, with an oral
form of levofloxacin. Physical examination revealed his
blood pressure was 140/82 mmHg, blood temperature
37.8C, pulse rate was 110 beats/minute, and respiratory
rate was 24 breaths/minute. Decreased breathing sounds
over the bilateral lower lung fields and bilateral pedal
edema were recorded, but lymphadenopathy and skin
lesions were not noted. The chest film revealedFigure 1. Chest X-ray and chest computed tomography before
admission showing cardiomegaly and bilateral exacerbated pleura
systemic steroid therapy showing obvious improvement; (C, D) ch
over both lungs, more on the right side with consolidations and w
cardiomegaly and some pericardial effusion.cardiomegaly, a new right massive pleural effusion and
worsening of the previously existing left pleural effusion
(Fig. 1A).
Laboratory analysis showed the white blood cell count as
15.5 k/cm3 (normal range Z 3.4ke9.1 k/cm3), hemoglobin
concentration as 8.8 g/dL (normal range Z 13.5e17 g/dL),
serumalbumin level as 2.5 g/dL (normal rangeZ3.5e5 g/dL),
glucose as 280 mg/dL (normal range Z 75e105 mg/dL) and
C-reactiveproteinas163.9mg/L (normal<5mg/L). Apositive
direct Coombs’ test was incidentally noticed while preparing
for blood transfusion. Urine analysis showed proteinuria
(>300 mg/dL). Diagnostic thoracocentesis resulted in an
exudate with predominant neutrophils. He was then treated
for pneumonia, complicated by parapneumonic pleural effu-
sion after above evaluation.
There was no improvement under the treatment of 3rd
generation cephalosporins and doxycycline, and a chest
tube was placed, but in vain. Chest computed tomography
(Figs. 1C and 1D) which showed bilateral loculated pleural
effusion, consolidations and ground glass opacities at the
bilateral lower lobes, cardiomegaly and trivial pericardial
effusion. Serial analysis of pleural fluids (Table 1) revealed
them to be consistently exudative in nature, and there was
an incidental finding of LE cells.and after systemic steroid therapy. (A) Chest X-ray on this
l effusion; (B) chest X-ray after right side decortication and
est computed tomography showing lobulated pleural effusions
ith ground glass opacities at bilateral lower lobes as well as
Table 1 Serial thoracocentesis data review
Variable Last admission Emergency department On Admission During operation
Side Left Right Left Right
Appearance Yellowish Reddish Reddish Reddish
RBC (cmm) 0 50000 Clot mostly 66000
WBC (cmm) 4000 340 Clot mostly 2950
Differential count(%)
Neutrophil 20 48 92 90
Eosinophil 2 12 d d
Monocyte 20 24 4 7
Lymphocyte 2 16 4 3
Mesothelial cell 44 d d d
Light’s criteria Exudate Exudate Exudate Exudate
Glucose (mg/dl) 110 85 99 83
pH value 7.03 6.92 6.8 d
Cytology Negative Negative LE cell Negative
Culture, Gram stain, Acid-fast stain Negative Negative Negative Negative
Systemic lupus erythematosus 141Because of the lack of improvement, the patient finally
received right side decortication for diagnostic and thera-
peutic purposes. The pathology of pleura and lung paren-
chyma disclosed reactive fibroblasts and proliferative
endothelial cells, infiltrated by neutrophils, and empyema
was suspected (Figs 2A and 2B) but no specific pathogen
was isolated. Despite decortication, with concomitant
antibiotic therapy, his effusion and fever persisted.
Due to the detection of LE cells in the pleural effusion,
a survey for SLE was performed. This disclosed decreased
serum complement at the C3 and C4 levels, a high titer
of antinuclear antibody (ANA) (1:1280, speckled type), and
positive anti-double-stranded DNA antibodies (1:160). After
establishing a diagnosis of SLE, high dosage parenteral
corticosteroid therapy (methylprednisolone 1 mg/kg/day)
was administered. His effusion, fever, and dyspnea signifi-
cantly improved. The following chest roentgenogram
(Fig. 1B) revealed complete resolution of the pleural
effusion.Figure 2. Decortication and lung biopsy. Reactive fibroblasts
lymphocytes, and plasma cells, with fragments of lung parenchym
acid fast and Gram stain showing negative findings. There is no ev
leukocytes showing aggregation with the necrotic debris. High powDiscussion
SLE is an imitator with various presentations. Overall, 90% of
patients with lupus are female and most are between 15 and
50 years of age.1 Therefore, making an early diagnosis is
tough in elderly males without a classical expression. In
a case series analysis of 520 patients with SLE conducted by
Dubois and Tuffanelli, pleuritis was observed in 45% of
patients, and accounted for 3% of the initial manifestations.2
In late onset SLE, pleuritis was observed more frequently,
especially among male patients,3 and may be the only
specific symptom at the initial hospital arrival.
Lupus-related pleural effusion is currently ascribed to
immune complex deposition and the binding of anti-dsDNA
antibodies to the mesothelium; it is usually exudative with
a low pH value, high protein, lactic dehydrogenase (LDH)
and negative culture results.4 The glucose level is often
low in rheumatoid related pleural effusion but indetermi-
nate in lupus.5 In addition, systemic high glucose level mayand proliferative endothelial cells infiltrated by neutrophils,
a due to acute inflammation. (A) Gomori-methenamine-silver,
idence of malignancy. HE, 400. (B) Many polymorphonuclear
er view HE, 600.
142 W.-T. Chang et al.interfere with the interpretation. The effusion usually
affects both sides and the white blood cell count is
observed in a range of 500 to 15,000/cmm. Nevertheless,
the differential count did not show a significant predomi-
nance of either neutrophils or lymphocytes.6
Non-infectious loculated pleural effusion, shown in this
case, also called sterile empyema or empyematous pleural
effusions, is usually seen in rheumatoid arthritis, pancrea-
titis and malignancy.5 To our knowledge, it is rare in
patients with SLE.7 To distinguish it from infectious etiol-
ogies is crucial, since super-infection in lupus pleural
effusion is possible. As for our case, the initial thor-
acocentesis was performed before antibiotic treatment
started and only 3-day therapy was prescribed prior to the
2nd pleural effusion study. The results both implicated
empyema (including a pH < 7.2 and elevated LDH, total
protein). The patient was initially treated with antibiotics
under the impression of infectious empyema, but in vain.
Great efforts to identify any microorganism including using
decorticated lung tissue failed. The importance of early
decortication of infectious empyema has been emphasized,
to achieve a better therapeutic response, as well as fewer
complications. Conversely, in empyematous pleural effu-
sion, even though decortication tends to decrease the
incidence of fibrothorax, trapped lung and symptomatic
restrictive disturbance but not superior to anti-
inflammatory treatment.5 In our case, neither antibiotics
nor decortication led to a therapeutic response. The
symptoms of the patient were not resolved until SLE was
diagnosed and treated. Thus, based on no pathogen being
identified in cultures and pathology specimens, treatment
with glucocorticoid for lupus related empyematous pleural
effusion is reasonable. However, culture-negative bacterial
empyema due to prior antibiotic exposure could not be
definitely excluded in our case.
Empyematous pleural effusion has been more commonly
reported in rheumatoid arthritis than other etiologies,
with the histologic characteristics of a “gritty” or “frozen”
pleural surface appearance, numerous small vesicles,
granules, and nodules. Effusion from ruptured rheumatoid
nodules into the pleural space is the supposed pathophys-
iology. Meanwhile, pleuritis in SLE is a result of a localized
immune process, with fewer features to distinguish it
from other inflammatory related pleural effusions. In our
case, the pathology finding of pleura revealed reactive
fibroblasts and proliferative endothelial cells infiltrated
by neutrophils, lymphocytes, and plasma cells; Gomori-
methenamine-silver and gram stain tests and a malignancy
survey showed negative results. The reported characteris-
tics of pleural biopsy in lupus erythematous pleural effusion
have been described as “the replacement of normal
mesothelial cells covered by epithelioid cells with nucle-
ated cells” and corresponds to the results in our patient.The presence of LE cells in the effusion, even though less
sensitive, is highly specific for the diagnosis of lupus
pleuritis and usually indicates an active disease status.8
They are composed of polymorphonuclear neutrophil
phagocytosis of apoptotic bodies induced by antinuclear
antibodies. Phagocytes from patients with lupus were
shown to engulf far less apoptotic material than phagocytes
from healthy subjects, implying an impaired “waste
disposal” function. C1q and anti-histone H1 antibody play
roles in the phagocytosis, by binding to cell debris, which
can then be engulfed by macrophages.1,8 Besides, some
reports indicate that the binding of anti-RNP antibody, as
well as anti-SS-A/Ro and anti-SS-B/La antibodies, is
predominantly involved in the development of cutaneous
LE lesions.9 However, LE cells are not frequently observed
and cannot be depended on to make diagnoses, no longer
belonging to the updating American College of Rheuma-
tology revised criteria.10
SLE does occur in elderly males with an initial
presentation as rapidly-progressive loculated pleural
effusion only. If laboratory analyses and thoracocentesis
give an indeterminate result, a clinical suspicion of auto-
immune disturbance is reasonable and may facilitate early
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